Biotage AB (publ) (STO: BIOT)

Market Cap	12.78B
Revenue (ttm)	2.12B
Net Income (ttm)	257.00M
Shares Out	80.05M
EPS (ttm)	3.20
PE Ratio	49.92
Forward PE	38.86
Dividend	1.60 (1.00%)
Ex-Dividend Date	n/a

Volume	80,721
Open	159.00
Previous Close	159.10
Day's Range	156.00 - 164.10
52-Week Range	122.20 - 202.20
Beta	0.85
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 19, 2025

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicol...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1969
• Employees: 674
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BIOT

Financial Performance

In 2023, Biotage AB's revenue was 1.86 billion, an increase of 18.90% compared to the previous year's 1.57 billion. Earnings were 246.00 million, a decrease of -8.21%.